Eupraxia Pharmaceuticals
EPRX · TORONTO
$6.87−$0.72 (−9.49%)TodayMarket closed ·
Prev close $7.59
Who owns EPRX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 31.7% of EPRX’s shares.
- Beutel, Goodman & Company Ltd.5.6%
- Disbrow (Robert)5.2%
- Manchester Management Company, L.L.C.4.1%
- Freedman (Joseph S)3.9%
- Next 6 largest institutions13.0%
- All other shareholders68.3%
| Holder | Shares | % of shares |
|---|---|---|
| Beutel, Goodman & Company Ltd. | 3.63M | 5.58% |
| Disbrow (Robert) | 3.37M | 5.18% |
| Manchester Management Company, L.L.C. | 2.63M | 4.05% |
| Freedman (Joseph S) | 2.54M | 3.91% |
| Affinity Asset Advisors LLC | 1.65M | 2.54% |
| Montalbano (John S.) | 1.56M | 2.40% |
| Balyasny Asset Management LP | 1.35M | 2.08% |
| Vivo Capital, LLC | 1.35M | 2.08% |
| Scotia Capital Inc. | 1.34M | 2.07% |
| PFM Health Sciences, LP | 1.21M | 1.86% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Beutel Goodman Small Cap Fund | 1.75M | 2.69% |
| IG Beutel Goodman Canadian Small Cap Fund | 561.73K | 0.86% |
| Matco Opportunities Fund | 300.00K | 0.46% |
| Matco Canadian Equity Income Fund | 167.00K | 0.26% |
| SEI Canadian Small Company Equity Fund | 160.62K | 0.25% |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.80M
- Days to cover
- 11.07
- % of shares outstanding
- 10.46%
- Average daily volume
- 614.41K
- Change since last report
- −10.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.